| Members |
targetComponentId |
| Contusion of face, scalp and neck NOS |
Contusion of head and/or neck (disorder) |
| kontusion i ansikte, på skalp och hals, förutom öga (ögon) |
Contusion of head and/or neck (disorder) |
| Contusion of multiple sites, NEC |
Contusion of multiple sites |
| Conversion disorder |
Dissociative disorder |
| Convulsion |
Seizure |
| Copper supplement |
Product containing copper (medicinal product) |
| Cordylobia |
Cordylobia anthropophaga |
| Corkscrew esophagus |
Diffuse spasm of esophagus |
| poäng enligt Cormack och Lehane |
Cormack and Lehane system (assessment scale) |
| majsolja, livsmedel |
Corn oil (substance) |
| Cornea guttata |
Corneal guttata (finding) |
| Corneal anesthesia |
Corneal anesthesia (finding) |
| Corneal endotheliolitis |
Corneal endotheliitis |
| Corneal epithelial and basement membrane dystrophy |
Epithelial basement membrane dystrophy (disorder) |
| hornhinnefragilitet, keratoglobus, blå senhinna och ledöverrörlighet |
Brittle cornea syndrome (disorder) |
| Coronary artery dissection |
Dissection of coronary artery (disorder) |
| klinisk handläggningsplan för riskskattning för kranskärlssjukdom |
Coronary heart disease risk clinical management plan |
| atresi av koronarostium |
Congenital atresia of coronary ostium |
| Coronavirus |
Subfamily Orthocoronavirinae (organism) |
| Corpus luteum of pregnancy |
Corpus luteum of pregnancy |
| Correction of tricuspid atresia |
Repair of tricuspid atresia |
| Corsodyl original mouthwash |
Product manufactured as oromucosal dose form (product) |
| Cortex contusion with open intracranial wound and unspecified state of consciousness |
Cortex contusion with open intracranial wound |
| Cortex contusion with open intracranial wound, with concussion, unspecified |
Contusion of cerebrum with open intracranial wound |
| Cortex contusion with open intracranial wound, with loss of consciousness of unspecified duration |
Contusion of cerebrum with open intracranial wound |
| Cortex contusion without open intracranial wound and with unspecified state of consciousness |
Cortex contusion without open intracranial wound |
| Cortex laceration with open intracranial wound and unspecified state of consciousness |
Cortex laceration with open intracranial wound |
| Corticosteroid binding globulin |
Corticotropin binding globulin |
| Corynebacterium flaccumfaciens |
Curtobacterium flaccumfaciens (organism) |
| Corynebacterium flaccumfaciens subsp betae |
Curtobacterium flaccumfaciens (organism) |
| Corynebacterium flaccumfaciens subsp oortii |
Curtobacterium flaccumfaciens (organism) |
| Corynebacterium flaccumfaciens subsp poinsettiae |
Curtobacterium flaccumfaciens (organism) |
| Corynebacterium liquefaciens |
Brevibacterium liquefaciens |
| Corynebacterium nigricans |
Corynebacterium aurimucosum (organism) |
| Corynebacterium paurometabolum |
Tsukamurella paurometabola (organism) |
| Corynebacterium vitarumen |
Corynebacterium vitaeruminis (organism) |
| räkning av aktiv ingrediens |
Count of active ingredient (attribute) |
| räkning av bas- och modifieringspar |
Count of base and modification pair (attribute) |
| räkning av bas i aktiv ingrediens |
Count of base of active ingredient |
| antal läkemedelstyper |
Count of clinical drug type (attribute) |
| Course |
Clinical course |
| Cowdria |
Ehrlichia |
| Cowdria ruminantium |
Ehrlichia ruminantium (organism) |
| koxartrolistetiskt bäcken |
Coxitis (disorder) |
| krabba, livsmedel |
Crab (substance) |
| kraniell manipulation |
Osteopathic cranial manipulative medicine (procedure) |
| Craniectomy, trephination, bone flap craniotomy for coagulation of choroid plexus |
Craniectomy |
| Craniectomy, trephination, bone flap craniotomy for total hemispherectomy |
Spinal cordotomy |
| Craniofenestria |
Craniolacunia |
| kraniosakral manipulation |
Osteopathic cranial manipulative medicine (procedure) |
| syndrom med kraniosynostos med ansiktsmissbildning och brakydaktyli |
Fibroblast growth factor receptor 3-related craniosynostosis (disorder) |
| Crax mitu |
Mitu mitu (organism) |
| kräfta, livsmedel |
Crayfish (substance) |
| Creation of arterioarterial bypass |
Arterial bypass graft |
| Creation of lesion of spinal cord by any modality |
Spinal cord destructive procedure |
| anläggande av oleotorax |
Procedure on thorax |
| allergi mot kromoglykat och relaterade antiallergikum |
Allergy to cromoglicic acid (finding) |
| natriumkromoglikat 0,8 mg/dos |
Sodium cromoglicate 800 microgram/actuation powder for inhalation |
| natriumkromoglikat 8,1 g, sprej |
Sodium cromoglicate 800 microgram/actuation powder for inhalation |
| tvärbunden hyaluronsyra 24 mg/ml, gel för injektion |
Hyaluronic acid only product in parenteral dose form |
| längd från hjässa till häl |
Recumbent body height (observable entity) |
| grymhet |
Cruel behavior |
| Crushing injury of multiple sites of shoulder AND/OR upper arm (disorder) |
Crushing injury of multiple sites of upper limb |
| Crushing injury of multiple sites, NEC |
Crushing injury of multiple sites |
| Crustacean |
Subphylum Crustacea (organism) |
| Cryptococcus albidus, variant albidus |
Naganishia albida (organism) |
| Cryptococcus antigen level |
Cryptococcus species antigen assay |
| mätning av kryptokockantigen |
Cryptococcus species antigen assay |
| Cryptococcus antigen level |
Cryptococcus species antigen assay |
| Cryptococcus neoformans, varietet gattii |
Cryptococcus gattii (organism) |
| Cryptogenic |
Unknown (origin) |
| Crystal arthropathy of other site |
Crystal arthropathy |
| kristallviolett tatuering |
Crystal violet tattoo |
| Crystalline lens and capsule |
Eye part |
| gurka, livsmedel |
Cucumber (substance) |
| Cucumovirus group |
Genus Cucumovirus (organism) |
| Curling esophagus |
Diffuse spasm of esophagus |
| Curvature of stomach |
Stomach part |
| kutan CD30-positiv lymfoproliferativ sjukdom |
Primary cutaneous CD30+ large T-cell lymphoma |
| kutant T-cellslymfom |
Cutaneous T-cell lymphoma |
| Cutaneous anaphylaxis |
Localized anaphylaxis |
| kutan eruption |
Eruption |
| cyanokobalamin 25 mikrogram, nässprej |
Product containing only cyanocobalamin in nasal dose form (medicinal product form) |
| cyanokobalamin 500 mikrogram, nässprej |
Cyanocobalamin 500 microgram/actuation nasal spray |
| cyankobolamin (^57^Co) 370 kBq/ml, oral lösning |
Cyanocobalamin (57-Co) only product in oral dose form |
| cyankobolamin (^58^Co) 370 kBq/ml, oral lösning |
Product containing only cyanocobalamin (58-Co) in oral dose form (medicinal product form) |
| CyberKnife |
Robotic radiation delivery system |
| cykliskt ödem |
Edema |
| cykloanemisering |
Destruction of ciliary body |
| Cyclopentolate hydrochloride + phenylephrine hydrochloride |
Product containing cyclopentolate and phenylephrine (medicinal product) |
| cyklopentolathydroklorid 0,5 %, ögondroppar |
Cyclopentolate hydrochloride 5 mg/mL eye solution |
| cyklopentolathydroklorid 0,5 %, ögondroppar för engångsbruk |
Cyclopentolate hydrochloride 5 mg/mL eye solution |
| cyklopentolathydroklorid 1 %, ögondroppar |
Cyclopentolate hydrochloride 10 mg/mL eye solution |
| cyklopentolathydroklorid 1 %, ögondroppar för engångsbruk |
Cyclopentolate hydrochloride 10 mg/mL eye solution |
| cyklopentolathydroklorid 2 %, ögondroppar |
Cyclopentolate hydrochloride 20 mg/mL eye solution |
| Cyclophosphamide 1g/vial injection |
Cyclophosphamide 1 g powder for solution for injection vial |
| Cyclophosphamide 1g/vial powder for injection |
Cyclophosphamide 1 g powder for solution for injection vial |
| Cyclophosphamide 200mg/vial injection |
Cyclophosphamide 200 mg powder for solution for injection vial |
| Cyclophosphamide 200mg/vial powder for injection |
Cyclophosphamide 200 mg powder for solution for injection vial |
| Cyclophosphamide 2g/vial injection |
Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Cyclophosphamide 500mg/vial injection |
Cyclophosphamide 500 mg powder for solution for injection vial |
FHIR